Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction

Table 2

Results of secondary endpoints.

	ATG Group (n=20)	BAS group (n=20)	p-value
One-year patient and graft survival	95%	95%	1
Infection	6 (30%)	7 (35%)	0.510
(i) Cholangitis (gram-negative bacteria)	3	1
(ii) Diarrheas (Clostridium difficile)	3	-
(iii) Pneumonia (Klebsiella pneumoniae)	-	2
(iv) Urinary tract infection (E. coli)	-	2
(v) MRSA infection (central vein catheter)	-	1
(vi) Oral Candidiasis	-	1
CMV infection	9 (45%)	7 (35%)	0.519
Adverse events related to ATG
Thrombocytopenia	3 (15%)
Thrombocytopenia + Leukopenia	1 (5%)

MRSA, methicillin-resistant Staphylococcus aureus.